David Page

David Page is an associate at Eaton Square since September 2021, leveraging a medical background and extensive experience in the medical and early-stage pharmaceutical sectors. Prior to this role, David served as a non-executive director at Drawbridge Pharmaceuticals Pty Ltd from July 2016 to December 2020, contributing to a startup biotech company with worldwide patents on 'Phaxan', an innovative intravenous anaesthetic agent. Additionally, David was the chair of the Corporate Advisory Board at Focus Care Solutions from 2016 to 2018, where involvement centered on a successful startup specializing in aged and dementia care in the home.